Latest filing published 06 Oct 2021 for XORTX Therapeutics Inc..
No signal scores available.
William Bruce Rowlands discloses dealings in XORTX Therapeutics Inc. to SEDI. We count 2 filings, every one of them for a trade on 24 September 2021.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 6 October 2021 came the latest disclosure, a transaction in XORTX Therapeutics Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations